Resolutions of the Annual General Meeting 2023 on the Financial Year 2021/2022 of BRAIN Biotech AG

8 March 2023, Zwingenberg (Germany) - At the virtual Annual General Meeting of BRAIN Biotech AG today (Frankfurt Stock Exchange / BNN / ISIN DE0005203947 / WKN 5203949), shareholders approved all proposals of the Executive and Supervisory Board with clear majorities. These items included the discharging of the acts of the Executive Board and the Supervisory Board, the election of two new members to the Supervisory Board and the approval of a new Executive Board compensation system, which links Executive Board compensation stronger to the long-term performance of the company.